Internal Med

Your Article Summary

See Latest Articles

Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09

Vanpouille C et al. – Recent studies have shown that although ACV therapy does not prevent HIV–1 transmission, it decreases plasma, genital, rectal, and seminal HIV–1 RNA levels. The decrease of HIV–1 load has been believed to be the result of an indirect mechanism and explained by reduction of HSV–2–mediated inflammation. The discovery of the direct inhibitory activity of ACV on HIV–1 reverse transcriptase brings new insights into the interpretation of these results. Also, it is important to understand why HSV–2–suppressive therapy with ACV did not reduce HIV–1 acquisition/transmission.

Related Articles

See all related articles

Effectiveness of Increasing Emergency Department Patients' Self-perceived Risk for Being Human Immunodeficiency Virus (HIV) Infected Through Audio Computer Self-interview–based Feedback About Reported HIV Risk Behaviors
Academic Emergency Medicine, 11/11/09    Relevance Score: 95%

HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09    Relevance Score: 95%

Mediators of HIV-related stigma and risk behavior in HIV infected young women
AIDS Care, 11/12/09    Relevance Score: 94%

Sperm May Play Leading Role In Spreading HIV
ScienceDaily, 10/27/09    Relevance Score: 94%

Female sex work and HIV risks in Croatia
AIDS Care, 10/29/09    Relevance Score: 93%

Today in Infectious Disease...keeping you current

Receive free subspecialty "5-minute updates" via email

Laser Therapy: Therapeutic Laser in the Treatment of Herpes Zoster
Practical Pain Management, 03/12/10

Poliomyelitis - Prevention in travellers
Australian Family Physician, 03/12/10

The Value of Neopterin and Procalcitonin in Patients with Sepsis
Southern Medical Journal, 03/12/10

 See all of Infectious Disease